Gene · 27063
Papers1,313
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,313
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Honokiol Suppresses Stemness and Sensitizes Triple-Negative Breast Cancer to Chemotherapy via YAP/TAZ-TEAD Inhibition. | Oncol Res | 2026 | 42769416 | PubTator, text mining | PubMed |
| Transcriptomic Profile of Genes Regulating Cellular Response to Extra- and Intracellular Stimuli in Porcine Ovarian Granulosa Cells During In Vitro Cultivation. | Int J Mol Sci | 2026 | 42353161 | PubTator, text mining | PubMed |
| Beta-Adrenergic Stimulation and MYH7 G256E Mutant Gene Dosage Drive Hypertrophic Cardiomyopathy Phenotype Penetrance. | bioRxiv | 2026 | 42282692 | PubTator, text mining | PubMed |
| Solamargine alleviates liver fibrosis by regulating YAP signaling in hepatic stellate cells. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2026 | 42244286 | PubTator, text mining | PubMed |
| Variant-to-function dissection of the 17q21.31 locus resolves ANKRD1 as a convergent regulatory target. | BMC Med Genomics | 2026 | 42057133 | PubTator, text mining | PubMed |
| Epigenetic remodeling in sarcoma promotes T-cell infiltration via modulation of the Hippo pathway. | J Immunother Cancer | 2026 | 41922083 | PubTator, text mining | PubMed |
| Obesity and Cancer: From Systemic Metabolic Reprogramming to Immunotherapy Paradox. | Metabolites | 2026 | 41893325 | PubTator, text mining | PubMed |
| Leveraging Large and Diverse Biobanks to Evaluate Gene-Disease Associations in Hypertrophic Cardiomyopathy. | J Pers Med | 2026 | 41893039 | PubTator, text mining | PubMed |
| Yifei Sanjie pill combined with gefitinib reduces the progression of EGFR-TKIs-resistant non-small cell lung cancer via YAP/ANKRD1 axis. | Phytomedicine | 2026 | 41865688 | PubTator, text mining | PubMed |
| GFPT2 drives sunitinib resistance of renal cell carcinoma via enzyme-dependent and -independent manners. | Int J Biol Sci | 2026 | 41800253 | PubTator, text mining | PubMed |
| Identification of MTURN as a trained immunity-related biomarker for heart failure via integrative transcriptomic machine learning analysis and experimental validation. | Front Immunol | 2026 | 41789108 | PubTator, text mining | PubMed |
| Decoding organ fibrosis: mechanistic insights and emerging therapeutic strategies. | Signal Transduct Target Ther | 2026 | 41786685 | PubTator, text mining | PubMed |
| ANKRD1 expression and functional mechanism in stomach adenocarcinoma. | Clin Transl Oncol | 2026 | 41770518 | PubTator, text mining | PubMed |
| ANKRD1 sustains a neurogenic BMSC niche and counters cognitive aging. | Int J Oral Sci | 2026 | 41764190 | PubTator, text mining | PubMed |
| Single-cell protein activity analysis reveals aberrant myogenesis and IGF2-PI3K pathway dependencies in MYOD1-mutant rhabdomyosarcoma. | Sci Adv | 2026 | 41758938 | PubTator, text mining | PubMed |
| Diagnostic Value of miR-1225-5p in Acute Coronary Syndrome and its Mechanism in ox-LDL Induced Human Coronary Artery Endothelial Cells Injury. | Clin Appl Thromb Hemost | 2026 | 41757871 | PubTator, text mining | PubMed |
| Expression Profile of Metabotropic Glutamate Receptors in Lung Adenocarcinoma: GRM5 and Validation of Its Targeting Drug Cinchonine. | Int J Mol Sci | 2026 | 41751933 | PubTator, text mining | PubMed |
| Biomechanical Forces in Prostate Cancer: Current Insights and Future Directions. | Cancers (Basel) | 2026 | 41749861 | PubTator, text mining | PubMed |
| Embeddings from language models are good learners for single-cell data analysis. | Patterns (N Y) | 2026 | 41726097 | PubTator, text mining | PubMed |
| IFNγ-induced memory in human macrophages is sustained by the durability of cytokine signaling itself. | J Exp Med | 2026 | 41706052 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/27063/papers